Microdosing for Creativity: What the Research Says

The science behind psilocybin and creative thinking is more nuanced than the headlines suggest. Here is what the evidence actually shows.

Wellness | ShroomTown.ca | May 2025

There is a certain romanticism attached to the idea of microdosing for creativity. Artists, writers, designers, and entrepreneurs have spoken openly about using sub-perceptual doses of psilocybin to unlock new ways of thinking, solve stubborn problems, and move through creative blocks. But how much of that is anecdote, and how much is science?

The honest answer is: both. The research into psilocybin and creative cognition is still young, but it is pointing in a genuinely interesting direction. This post unpacks what the studies actually found, what their limitations are, and what that means for anyone curious about using a low-dose approach to support their creative practice.

What Do We Mean by “Creativity”?

Before diving into the research, it is worth clarifying what scientists are actually measuring when they study creativity. Psychologists typically break it into two distinct cognitive processes:

• Divergent thinking: The ability to generate many possible solutions to an open-ended problem. This is the brainstorm mode, where novelty and volume of ideas matter.
• Convergent thinking: The ability to identify the single best or most correct solution to a well-defined problem. This is the editing mode, where logic and focus take over.

Most creativity research uses standardised tests to measure both. The Alternate Uses Task, for example, asks participants how many different uses they can imagine for a common object like a brick or a paperclip. The Remote Associates Test measures convergent thinking by asking participants to find the common link between three seemingly unrelated words.

This distinction matters because, as we will see, psilocybin does not appear to affect both types of thinking equally.

What the Research Actually Found

The Leiden University Study (2018)

One of the most widely cited studies in this space was conducted by researchers at Leiden University in the Netherlands. Participants attended a microdosing event organised by the Psychedelic Society of the Netherlands, completing creativity assessments before and after taking a self-selected, low dose of truffles containing psilocybin.

The results were notable. Participants showed improvements in both divergent and convergent thinking after dosing. Fluid intelligence, which includes the ability to reason through novel problems, also appeared to increase. The researchers suggested that psilocybin may work by quieting the default mode network, the brain’s self-referential “autopilot” system, allowing for looser, more associative thinking.

The limitation worth knowing: this was a naturalistic study without a placebo control group, meaning expectation effects and self-selection bias cannot be ruled out. Participants knew they were taking psilocybin, and people who attend microdosing events are already likely to believe it works.

The Imperial College London Research Programme

Researchers at Imperial College London have conducted extensive work on how psilocybin affects brain connectivity. While much of their research focuses on therapeutic doses rather than microdoses specifically, their findings on the default mode network have direct relevance to creativity.

Their neuroimaging studies found that psilocybin significantly reduces activity in the default mode network while simultaneously increasing connectivity across brain regions that do not normally communicate. This “entropic brain” effect, their term for increased neural disorder or flexibility, may explain why people on psilocybin often report thinking in ways that feel genuinely novel rather than just variations on familiar patterns.

The Maastricht University Microdosing Study (2022)

A more rigorous double-blind, placebo-controlled study from Maastricht University offered a more tempered picture. Participants received either a low dose of psilocybin or a placebo and completed a battery of cognitive tests. The results showed modest improvements in some measures of creative thinking, but the effects were smaller and less consistent than earlier naturalistic studies had suggested.

Importantly, the researchers noted that individual responses varied considerably. Some participants showed meaningful gains in divergent thinking while others showed no change or even slight decreases in analytical performance. This variability points to something the microdosing community has observed informally for years: the same dose can affect different people in very different ways depending on mindset, context, and neurological baseline.

The Convergent Thinking Caveat

Here is where the picture gets more complicated. While psilocybin appears to consistently support divergent, generative thinking, the evidence for convergent thinking is less clear and in some cases points in the opposite direction.

Some studies have found that even sub-perceptual doses can slightly reduce performance on tasks requiring focused, logical analysis. The same loosening of cognitive filters that allows for more creative associations may also make it slightly harder to lock in on a single correct answer under time pressure.

For most creative workers, this tradeoff is intuitive. A microdose day might be ideal for ideation, exploration, and generating new directions. It may be less ideal for detailed editing, contract review, or precise technical work that requires sustained linear focus.

If your creative process involves both modes, thinking about when and how you dose relative to the type of work you are doing is worth considering carefully.

Why Psilocybin May Support Creative States

Pulling together the research, a few mechanisms seem to be at play:

• Default mode network suppression: The brain’s tendency to replay familiar patterns, ruminate, and default to habitual thinking is reduced. This creates space for genuinely novel associations.
• Increased cross-network connectivity: Regions of the brain that rarely communicate begin sharing information, which researchers believe underlies the sense of unexpected connections and insights.
• Reduced psychological rigidity: Psilocybin appears to temporarily lower the brain’s tendency to model the world through fixed categories, which may allow for more flexible, lateral thinking.
• Heightened present-moment awareness: For many people, a sub-perceptual dose brings a mild but noticeable increase in sensory attention, which can make the immediate environment feel more interesting and stimulating.

For those incorporating a structured microdosing practice into their creative routine, ShroomTown’s Focus Caps are designed with exactly this kind of intentional, sub-perceptual use in mind, offering a consistent and measured approach to each session.

What the Research Does Not Tell Us (Yet)

It is equally important to be honest about the gaps. The current body of research on microdosing specifically, as opposed to full-dose psilocybin, is still small. Most studies are limited by small sample sizes, self-selected participants, and short observation windows. Long-term effects of regular microdosing on creative cognition have not been studied in any rigorous way.

There is also the question of what researchers sometimes call the “expectation effect.” People who believe microdosing will make them more creative often report that it does. Teasing out how much of that is pharmacological and how much is psychological is genuinely difficult, and the honest answer is that nobody knows for certain yet.

None of this means the anecdotal reports from thousands of people should be dismissed. Personal experience is data, even if it is not controlled data. But approaching microdosing for creativity with calibrated expectations, rather than treating it as a guaranteed unlock, is both more accurate and more useful.

How to Approach Microdosing With Your Creative Work

If you are curious about exploring psilocybin in a low-dose creative context, a few practical considerations are worth holding onto:

• Match the dose to the task. Generative, exploratory work tends to benefit more than precise, analytical work. Plan your schedule accordingly.
• Track your responses. Keep a simple journal on dose days noting your mood, energy, focus quality, and creative output. Patterns will emerge over time that are specific to you.
• Respect the off days. Most protocols include non-dose days deliberately. These integration days are when insights from dose days tend to crystallise and translate into actual work.
• Start lower than you think you need to. A sub-perceptual dose should not be noticeable as an altered state. If you are feeling it strongly, the dose is likely too high for creative work purposes.

For those who prefer a ritual-based approach to creative sessions rather than a daily capsule routine, the ShroomTown Precision Bar offers precise, portioned dosing in a format well suited to a more intentional, sit-down creative practice.

The Bottom Line

The research into microdosing for creativity is genuinely promising, but it is early and imperfect. What the studies suggest, at least directionally, is that sub-perceptual doses of psilocybin may support divergent, generative thinking by loosening habitual cognitive patterns and increasing cross-network brain connectivity. The effect on convergent, analytical thinking is more mixed.

For creative practitioners, that is actually useful signal. Microdosing is not a magic switch that makes everything better. It is a tool, and like any tool, its value depends on using it in the right context, with realistic expectations, and with enough self-awareness to know when it is working for you and when it is not.

The most consistent finding across both the research and the broader community is this: intention matters. People who approach microdosing with a clear purpose, a structured protocol, and the patience to actually observe their own responses tend to get more out of it than those who treat it as a passive supplement.

That, at least, is something both the science and the anecdote agree on.